Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

32
Number of overlapping holdings
16.7%
% of IBB's 212 holdings also in IDNA
71.1%
% of IDNA's 49 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IBB |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 9.9% | 5.9% | 5.9% | |
REGENERON PHARMACEUTICALS | 5.3% | 3.1% | 3.1% | |
BIONTECH SE SPONSORED ADR | 2.5% | 5.0% | 2.5% | |
INCYTE CORP | 1.3% | 4.9% | 1.3% | |
MODERNA, INC. | 1.5% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IDNA
VERTEX PHARMACEUTICALS INC | 8.0% | |
AMGEN INC | 6.9% | |
GILEAD SCIENCES INC | 4.0% | |
IQVIA HOLDINGS INC | 3.7% | |
ALNYLAM PHARMACEUTICALS INC | 3.2% | |
ARGENX SE ADR | 3.1% | |
METTLER-TOLEDO INTERNATIONAL | 2.7% | |
ILLUMINA INC | 2.3% | |
WATERS CORP | 2.3% | |
REGENERON PHARMACEUTICALS | 2.2% |
IBB Underweight Relative to IDNA
EXELIXIS INC | -5.7% | |
BEIGENE, LTD. | -4.8% | |
ROCHE HOLDING LTD | -4.4% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% | |
REVOLUTION MEDICINES, INC. | -4.1% | |
SANOFI-AVENTIS | -4.0% | |
ARCELLX, INC. | -3.6% | |
INCYTE CORP | -3.5% | |
GSK PLC | -3.4% | |
MERCK & CO. INC. | -3.3% |